Cairns Private Hospital
Part of Ramsay Health Care

Cairns Private Hospital specialist Paul Eliadis  AM

Dr Paul Eliadis AM


Clinical Haematologist and Medical Oncologist

With over 35 years’ experience in Clinical Haematology and Oncology, Dr Paul Eliadis is at the peak of his career.

In 1988 he, along with Dr Ian Bunce and Dr Trevor Olsen, established The Wesley Clinic for Haematology and Oncology. Since then, this clinic has developed into the largest and most progressive provider of haematology and oncology day services in Australia, and is today known as Icon Cancer Care.  Dr Eliadis is considered an expert in the specialties of Clinical Haematology and Medical Oncology, he lists his particular interests as the management of malignant disease and stem cell transplantation. These include malignant lymphoma, Hodgkin’s disease, acute and chronic leukaemias, colorectal cancers, other malignancies of the gastro-intestinal tract, breast cancer, lung cancer, sarcomas, prostate cancer, malignant tumors of the central nervous system and malignancies of the genitourinary tract.

Dr Paul Eliadis works closely with Radiation Oncologists in managing patients with malignant disease who require concurrent chemo-radiotherapy - these include patients with cancer of the head and neck, oesophagus and rectum.  As a Director of the Icon Foundation, Dr Eliadis is passionate about clinical research and continues to support medical research that explores promising opportunities in cancer care. He is involved in numerous clinical trials in relation to malignant disease, both as principal investigator and sub-investigator.  Dr Eliadis currently practices at Icon Cancer Care Wesley and visits Cairns where he runs a monthly clinic at Cairns Private Hospital. 

Dr Eliadis is committed to ensuring his patients receive the highest quality treatment and care.

In January 2020, he was awarded an Order of Australia (AM) for significant service to medicine as a Clinical Haematologist and commitment to charitable initiatives.

Management of malignant disease and stem cell transplantation